Johnson & Johnson(us:JNJ)
153.25
-7.59%
Updated on 2025-04-02
Open:160.73
Close:153.25
High:161.81
Low:153.13
Prev Close:165.84
Volume:23.30M
Turnover:3.63B
Turnover Ratio:0.97%
Shares:2.41B
MarketCap:369.31B
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 142 | 8920273 | 0.37% | 6 | 53 | 70 |
| 2024-03-31 | 3797 | 1650800572 | 68.59% | 140 | 1510 | 1797 |
| 2023-12-31 | 3821 | 1670974460 | 69.42% | 308 | 1269 | 1946 |
| 2023-09-30 | 3716 | 1634244181 | 62.88% | 138 | 1165 | 2119 |
| 2023-06-30 | 3714 | 1774292452 | 68.28% | 157 | 1549 | 1660 |
| 2023-03-31 | 3683 | 1753680608 | 56.21% | 127 | 1614 | 1631 |
| 2022-12-31 | 3719 | 1816267695 | 69.47% | 268 | 1563 | 1532 |
| 2022-09-30 | 3605 | 1777311465 | 67.92% | 94 | 1627 | 1521 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-06-30 | Vanguard Group Inc | 229041796 | 9.52% | 103292 | 0.04% |
| 2024-06-30 | Blackrock Inc. | 198186824 | 8.23% | 8460056 | 4.46% |
| 2024-06-30 | State Street Corp | 133091723 | 5.53% | -428058 | -0.32% |
| 2024-06-30 | Geode Capital Management, Llc | 55102121 | 2.29% | 1779157 | 3.34% |
| 2024-06-30 | Morgan Stanley | 42069269 | 1.75% | -480674 | -1.13% |
| 2024-06-30 | State Farm Mutual Automobile Insurance Co | 31675492 | 1.32% | 0 | |
| 2024-06-30 | Jpmorgan Chase & Co | 29583659 | 1.23% | -271124 | -0.91% |
| 2024-06-30 | Norges Bank | 29092369 | 1.21% | 3115327 | 11.99% |
| 2024-06-30 | Northern Trust Corp | 28430009 | 1.18% | -202287 | -0.71% |
| 2024-06-30 | Price T Rowe Associates Inc /Md/ | 24909195 | 1.03% | 3074836 | 14.08% |
About
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Address:One Johnson & Johnson Plaza
Website:http://www.jnj.com
Market Movers